Page last updated: 2024-09-05

2'-hydroxyflavanone and Kidney Neoplasms

2'-hydroxyflavanone has been researched along with Kidney Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Awasthi, S; Figarola, JL; Horne, D; Riggs, A; Singhal, J; Singhal, SS1
Awasthi, S; Lelsani, P; Nagaprashantha, LD; Prokai, L; Singhal, J; Singhal, SS; Vatsyayan, R1

Reviews

1 review(s) available for 2'-hydroxyflavanone and Kidney Neoplasms

ArticleYear
2'-Hydroxyflavanone: A promising molecule for kidney cancer prevention.
    Biochemical pharmacology, 2015, Aug-01, Volume: 96, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Benzopyrenes; Carcinogens; Carcinoma, Renal Cell; Dimethylnitrosamine; Drug Resistance, Neoplasm; Flavanones; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Mice; Mutation; Signal Transduction; Von Hippel-Lindau Tumor Suppressor Protein

2015

Other Studies

1 other study(ies) available for 2'-hydroxyflavanone and Kidney Neoplasms

ArticleYear
2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.
    Carcinogenesis, 2011, Volume: 32, Issue:4

    Topics: 20-Hydroxysteroid Dehydrogenases; Animals; Carcinoma, Renal Cell; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; ErbB Receptors; Flavanones; Glutathione S-Transferase pi; Humans; Kidney Neoplasms; Mice; Mutation; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Von Hippel-Lindau Tumor Suppressor Protein; Xenograft Model Antitumor Assays

2011